A guide to oral medications for psoriasis


LearnSkinA guide to exploring different treatment options for psoriasisA guide to oral medications for psoriasis
  • When is psoriasis moderate-to-severe?
  • Oral systemic therapies for psoriasis
  • Talk to your healthcare provider

Treating moderate-to-severe psoriasis often requires systemic therapies, or medications that work by reducing inflammation throughout the body. Some systemic therapies, called biologic therapies, are given with injections or infusions. Several other treatment options are taken as oral medications.

Below is a look at the different types of oral medications that are available, as well as emerging therapies that are taken as oral medications.

When is psoriasis moderate-to-severe?

While there are no true universal guidelines for categorizing psoriasis severity, there are factors that are consistently used in assessments. One is the total body surface area (BSA) that is affected by psoriasis.

  • Less than 3 percent is mild
  • 3 to 10 percent is moderate
  • More than 10 percent is severe

However, the impact on a person’s quality of life and functioning is equally important, and often more important, than body surface area. Small amounts of psoriasis that affect the face, hands, genitals, or other highly visible or highly sensitive areas of the body can be considered moderate to severe because they often cause high amounts of distress, physical discomfort, and limit functioning.

The National Psoriasis Foundation has begun categorizing severity based on what treatments are required to manage psoriasis. With this method, psoriasis that can be managed with topical therapies alone is considered mild, and psoriasis that requires systemic therapies is considered moderate-to-severe. It’s common for treatment to include a combination of topical and systemic therapies.

Oral systemic therapies for psoriasis

There are multiple types of oral medications used to treat moderate-to-severe psoriasis. Some have been around for decades. Others have been around for a decade or less. And there are also emerging therapies that are in clinical trials or beginning to become available.

Traditional systemic medications

These are the oral medications that have been used in psoriasis treatment for decades. This list includes immunosuppressants and a type of drug called an oral retinoid.

  • Immunosuppressants. As the name implies, these medications suppress the immune system. Suppressing the immune system helps reduce inflammation throughout the body but also reduces the body’s ability to fight infections.
  • Oral retinoid. Retinoids are compounds derived from vitamin A or synthetic versions of vitamin A. These drugs can help control the rate at which cells multiply. The oral retinoid that is used to treat psoriasis reduces inflammation and skin cell division. This may be used in combination with phototherapy.

These medications are often affordable but also have limitations. Immunosuppressants require regular monitoring for blood cell counts, liver function, kidney function, and pregnancy. Treatment with an oral retinoid requires a person to avoid pregnancy and breastfeeding for at least three years after discontinuing treatment.

Targeted treatments

Newer oral medications are sometimes called targeted therapies because they target specific proteins in the inflammatory pathways that underlie psoriasis symptoms. An inflammatory pathway is a series of chemical reactions that regulates the activation of immune cells and the release of inflammatory chemicals.

Targeted therapies include:

  • Oral small molecule drugs. These are drug compounds that can easily enter cells and mimic the behavior of natural substances. Examples include drugs called TYK2 inhibitors and PDE4 inhibitors. These drugs are not typically as effective as biologics but are still an excellent treatment option for many people, with a lower risk of side effects and cost.
  • Targeted oral peptides. These are a new and emerging therapy. Peptides are compounds that are larger than small molecules but smaller than proteins. Peptide therapies are known to be effective at blocking protein-protein interactions (like the kind that occur in an inflammatory pathway). The goal is to develop oral medications that can achieve treatment outcomes close or equal to biologics.

Talk to your healthcare provider

It’s important to remember that there is no best treatment for psoriasis. Different treatments work for different people. Treatment can also change over time, and it’s common to switch from one medication to another. Talk to your healthcare provider about any questions

For questions about psoriasis treatment, your best source of information will be your healthcare provider.

Sources: Sanyam Mehta and Nishad C. Sathe. Plaque... + 22
  1. Sanyam Mehta and Nishad C. Sathe. Plaque Psoriasis. StatPearls. September 14, 2025.
  2. Mayo Clinic. Psoriasis. December 17, 2025.
  3. Heidi Godman. Can medication tame chronic inflammation? Harvard Health Publishing. April 1, 2022.
  4. National Psoriasis Foundation. Reassessing Psoriasis Severity. January 16, 2024.
  5. Danielle Yee and April W. Armstrong. Re-Classification of Psoriasis Severity: Perspectives and Controversy. Journal of Psoriasis and Psoriatic Arthritis, 2022. Vol. 7, No. 1.
  6. International Psoriasis Council. Recategorization of Psoriasis Severity. October 2025.
  7. National Psoriasis Foundation. Oral Treatments. March 25, 2025.
  8. Dermatology Times. Table: 40 years of psoriasis therapeutics. August 2019. Vol. 40, No. 8.
  9. Judith Stewart. Otezla FDA Approval History. Drugs.com. July 15, 2024.
  10. Judith Stewart. Sotyktu FDA Approval History. Drugs.com. March 9, 2026.
  11. Dylan Barrett. Targeted therapy for psoriasis: A focus on tyrosine kinase 2 inhibitors. PsOPsA Hub. August 12, 2024.
  12. Anastasia Drakos, Tiago Torres, and Ronald Vender. Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics, 2024. Vol. 16, No. 1.
  13. NCI Dictionary of Cancer Terms. Retinoid. March 12, 2026.
  14. Patrick M. Zito, Preeti Patel, and Thomas Mazzoni. Acitretin. StatPearls. February 28, 2024.
  15. Alan Menter, Joel M. Gelfand, et al. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. Journal of the American Academy of Dermatology, 2020. Vol. 82, No. 6.
  16. Linda Stein Gold, Kilian Eyerich, et al. Oral Peptide Therapeutics as an Emerging Treatment Modality in Immune-Mediated Inflammatory Diseases: A Narrative Review. Advanced Therapy, 2025. Vol. 42, No. 7.
  17. George Martin. Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors. Dermatology and Therapy, 2023. Vol. 13, No. 2.
  18. Sally Hannoodee and Dian N. Nasuruddin. Acute Inflammatory Response. StatPearls. June 8, 2024.
  19. NCI Dictionary of Cancer Terms. Small-molecule drug. Accessed March 18, 2026.
  20. Michelle W. Y. Southey and Michael Brunavs. Introduction to small molecule drug discovery and preclinical development. Frontiers in Drug Discovery. November 29, 2023.
  21. David Strawn, James G Krueger, et al. Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis. JCI Insight, 2025. Vol. 10, No. 24.
  22. Anusree Subramonian and Melissa Walter. Newer Biologics for the Treatment of Plaque Psoriasis. Canadian Agency for Drugs and Technologies in Health. September 2021.
  23. Samantha C. Shapiro. What’s Next When Creams for Psoriasis Aren’t Working? GoodRx. November 21, 2024.
Written by Jameson Kowalczyk.
Medically reviewed by Joanne Perron, MD, MPH.March, 2026
Updated onJuly, 2026
Written by Jameson Kowalczyk.
Medically reviewed by Joanne Perron, MD, MPH.March, 2026
Updated onJuly, 2026
  • When is psoriasis moderate-to-severe?
  • Oral systemic therapies for psoriasis
  • Talk to your healthcare provider

Featured content

Condition Metamorphosis: PsO
Interactive

Condition Metamorphosis: PsO

If you have psoriasis you need to ask yourself this question
Article

If you have psoriasis you need to ask yourself this question

Psoriasis is a different experience for everyone. Answering this question can help you understand your experience.

How psoriasis affects mental health
Article

How psoriasis affects mental health

Learn how to recognize the signs of depression, as well as tips on how to seek help.

My psoriasis treatment isn’t working, what are my options?
Article

My psoriasis treatment isn’t working, what are my options?

A look at topical therapies, oral medications, biologics, and phototherapy for psoriasis.

Why people with psoriasis need a primary care physician
Article

Why people with psoriasis need a primary care physician

While psoriasis can feel all-encompassing, you need to focus on these other areas of your health and wellbeing.

Questions to ask when changing psoriasis treatments
Article

Questions to ask when changing psoriasis treatments

Why switching therapies is common in psoriasis treatment and what you’ll want to discuss with your healthcare provider.

AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.

ask-mdask-md
AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.